Clinical Trials Logo
  1. Home
  2. Staphylococcal Infection
  3. NCT02812446

Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development

Staphylococcal Infection Clinical Trial

Official title:
Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development

Clinical Trial Summary

The purpose of this study is to identify bacterial and/or clinical features involved in the pathogenesis of Staphylococcus aureus implant-associated infections (IAI). Materials & methods: In total, 57 IAI S. aureus and 31 nasal carriage (NC) S. aureus isolates were studied. Staphylococcus aureus genetic background was obtained by microarray analysis. Multilocus sequence typing was performed to determine clonal complexes (CC). Biofilm production was investigated by resazurin and crystal violet methods

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02812446
Study type Observational
Source Nantes University Hospital
Contact
Status Completed
Phase N/A
Start date February 2012
Completion date December 2013
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT02899702 - Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children Phase 4
Completed NCT00770341 - A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002) Phase 3
Completed NCT00352612 - Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections Phase 4
Completed NCT00279864 - The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection N/A
Completed NCT00735839 - V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED) Phase 1
Completed NCT00814151 - MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial N/A
Completed NCT00846105 - Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA) N/A
Completed NCT02284555 - Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment) Phase 4
Completed NCT01592214 - Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73 Phase 1
Completed NCT01827358 - Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants Phase 2
Completed NCT00729937 - Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" Phase 2/Phase 3
Completed NCT00730028 - Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus Phase 2